GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case Report.

IF 5.7 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes technology & therapeutics Pub Date : 2024-10-03 DOI:10.1089/dia.2024.0367

Gida Ayada, Sagit Zolotov, Raya Cohen, Tal Lavi, Muhammad Abdul-Ghani, Naim Shehadeh, Afif Nakhleh

引用次数: 0

查看原文本刊更多论文

GLP-1 受体激动剂治疗囊性纤维化相关糖尿病：病例报告。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes technology & therapeutics 医学-内分泌学与代谢

CiteScore

10.60

自引率

14.80%

发文量

145

审稿时长

3-8 weeks

期刊介绍： Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.